INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,547,583 | +48.0% | 317,856 | +79.7% | 5.57% | +63.7% |
| Q2 2023 | $11,182,605 | -19.9% | 176,856 | -31.4% | 3.40% | -12.6% |
| Q1 2023 | $13,957,745 | +19.0% | 257,856 | +16.2% | 3.89% | +7.5% |
| Q4 2022 | $11,733,964 | +13.9% | 221,856 | 0.0% | 3.62% | +9.7% |
| Q3 2022 | $10,303,000 | -83.7% | 221,856 | +6057.5% | 3.30% | +401.4% |
| Q2 2022 | $63,156,000 | +201.7% | 3,603 | -92.9% | 0.66% | -86.0% |
| Q1 2022 | $20,930,000 | +253.3% | 50,956 | -55.1% | 4.72% | +257.6% |
| Q4 2021 | $5,924,000 | +100.3% | 113,456 | +42.8% | 1.32% | +85.1% |
| Q3 2021 | $2,957,000 | -8.8% | 79,456 | 0.0% | 0.71% | -16.7% |
| Q2 2021 | $3,243,000 | +20.1% | 79,456 | 0.0% | 0.86% | +19.9% |
| Q1 2021 | $2,700,000 | +6.8% | 79,456 | 0.0% | 0.71% | +3.5% |
| Q4 2020 | $2,527,000 | +296.7% | 79,456 | +220.4% | 0.69% | +235.0% |
| Q3 2020 | $637,000 | +10.0% | 24,800 | +7.8% | 0.21% | +7.3% |
| Q2 2020 | $579,000 | +64.5% | 23,000 | 0.0% | 0.19% | +20.0% |
| Q1 2020 | $352,000 | – | 23,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |